Please login to the form below

Not currently logged in
Email:
Password:

Shires's Jeffrey Jonas to lead Sage

CNS appoints CEO alongside new CMO and CFO

Jeffrey Jones, Sage TherapeuticsSage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO.

The other key appointments are AstraZeneca's Stephen Kanes as chief medical officer and Santhera's Kimi Iguchi as chief financial officer.

The changes come two years after the formation of the central nervous system (CNS) specialist and signal the expected growth of Sage as it moves its research programmes into late-stage development.

This will be headed by Dr Jonas (pictured), who was president of regenerative medicines at Shire and has a career in the life sciences that spans more than 20 years and includes CNS experience.

His roles prior to joining Shire include serving as executive VP of Isis Pharmaceuticals and chief medical officer of Forest Laboratories.

Dr Jonas also has entrepreneurial experience, founding Avax technologies and Sceptor Industries.

His new colleagues include Dr Kanes, who was most recently executive director/ therapeutic area clinical director for the inflammation, neuroscience and respiratory GMED division of AZ.

Dr Kanes also has experience as a faculty member in the psychiatry department at the University of Pennsylvania School of Medicine

Iguchi joins from her role as chief operating officer, North America, for Santhera.

Her previous positions include VP, finance, for Cyberkinetics Neurotechnology Systems, as well as senior financial roles at Biogen and Millennium Pharmaceuticals.

16th August 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics